Signal
Click here to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
In a significant finding, two-dose Ivermectin prophylaxis has led to 73 per cent reduction in COVID-19 infection among healthcare workers (HCWs), who are more likely to contract the virus given their nature of job.
The findings of the study conducted by AIIMS-Bhubaneswar between September 20 and October 19 is set to give a new dimension to the ongoing research on the behaviour of SARS-CoV2 and prevention and treatment of COVID-19.
Ivermectin is one among several potential drugs explored for its therapeutic and preventive role in COVID-19 infection. The study conducted by 12 physicians of AIIMS-BBSR aimed at exploring the association between Ivermectin prophylaxis and development of COVID-19 infection.
“Considering the fact that Ivermectin had been shown to have diverse mechanisms by which it successfully attacks the SARS-CoV-2, we decided to use it. The Ivermectin has a proven safety profile as a safe drug which has been used for many decades. The encouraging results of a study from Egypt prompted us to explore its role as prophylaxis for HCWs,”
Read The New Indian Express article Ivermectin prophylaxis leads to 73 per cent reduction in Covid infection
See also
FLCCC WEEKLY UPDATE – Why is the WHO using the disinformation playbook? + Q&A
